Moore Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$1.02M	–	565
2023 Q2	$1.02M	Sell	10,000 -48,301	-83%	-$4.92M	0.02%	274
2023 Q1	$5.3M	Buy	+58,301	New	+$5.3M	0.11%	120
2018 Q4	–	Sell	-15,000	Closed	-$1.23M	–	302
2018 Q3	$1.23M	Buy	+15,000	New	+$1.23M	0.03%	182